Bulletin 2012/02 - European Patent Office
31.12.2012 • Views
Share Embed Flag

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(C07D) II.1(1)<br />

(51) C07D 209/22 (11) 1 950 200 B1<br />

A61K 31/40<br />

(25) En (26) En<br />

(21) 08001265.1 (22) 31.03.1995<br />

(84) AT BE CH DE DK ES FR GB GR IE IT LI LU NL<br />

PT SE<br />

(43) 30.07.2008<br />

(30) 01.04.1994 US 221916<br />

(54) • [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-<br />

(phenylmethyl)-11H-indol-4-yl]oxy]essigsäure<br />

methyl ester als sPLA2 inhibitor<br />

• [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-<br />

(phenylmethyl)-11H-indol-4-yl]oxy]acetic<br />

acid methyl ester as sPLA2 inhibitor<br />

• Ester méthylique de l'acide acétique de [[3-<br />

(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]<br />

comme<br />

Inhibiteur de sPLA2<br />

(73) ELI LILLY AND COMPANY, Lilly Corporate<br />

Center, Indianapolis, IN 46285, US<br />

(72) Bach, Nicholas James, Freeport, IL 61032,<br />

US<br />

Draheim, Susan Elizabeth, Indianapolis Indiana<br />

46220, US<br />

Dillard, Robert Delane, Zionsville Indiana<br />

46077, US<br />

(74) Williams, Richard Andrew Norman, Harrison<br />

Goddard Foote 40- 43 Chancery Lane,<br />

London WC2A 1JA, GB<br />

(60) 10180825.1 / 2 341 045<br />

(62) 0<strong>02</strong>03897.4 / 1 081 135<br />

953<strong>02</strong>166.4 / 0 675 110<br />

(51) C07D 209/42 (11) 1 636 185 B1<br />

(25) De (26) De<br />

(21) 04737<strong>02</strong>9.1 (22) 18.06.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

AL HR LT LV MK<br />

(43) 22.03.2006<br />

(86) CH 2004/000374 18.06.2004<br />

(87) WO 2004/113293 2004/53 29.12.2004<br />

(30) 24.06.2003 CH 110903<br />

(54) • NEUE KRISTALLINE FORMEN VON PERI-<br />

NDOPRIL ERBUMINE<br />

• NOVEL CRYSTALLINE FORMS OF PERI-<br />

NDOPRIL ERBUMINE<br />

• NOUVELLES FORMES CRISTALLINES DE<br />

PERINDOPRIL ERBUMINE<br />

(73) Les Laboratoires Servier, 22, rue Garnier,<br />

92278 Neuilly sur Seine, FR<br />

(72) STRÄSSLER, Christoph, CH-8050 Zürich, CH<br />

LELLEK, Vit, CH-8046 Zürich, CH<br />

FÄSSLER, Roger, CH-8246 Langwiesen, CH<br />

(74) Braun, André jr., et al, Braunpat Braun Eder<br />

AG Reussstrasse 22 Postfach, 4015 Basel,<br />

CH<br />

(51) C07D 209/82 (11) 1 569 904 B1<br />

C07D 279/22 C07D 471/04<br />

A61K 31/335 A61K 31/422<br />

A61K 31/426 A61K 31/185<br />

A61K 31/538 A61K 31/5415<br />

A61K 31/403 A61K 31/55<br />

A61P 3/00<br />

(25) En (26) En<br />

(21) 03772525.6 (22) 21.11.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 07.09.2005<br />

(86) IB 2003/005371 21.11.2003<br />

(87) WO 2004/048333 2004/24 10.06.2004<br />

(30) 26.11.20<strong>02</strong> US 429221 P<br />

09.05.2003 US 469368 P<br />

18.11.2003 US 715622<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) • SUBSTITUIERTE AKRYLALKANSÄURE-<br />

DERIVATE ALS PPAR PAN-AGONISTEN<br />

MIT STARKER BLUTZUCKERGEHALT-<br />

SENKENDER UND LIPIDBLUTSPIEGEL-<br />

SENKENDER WIRKUNG<br />

• SUBSTITUTED ARYLALCANOIC ACID<br />

DERIVATIVES AS PPAR PAN AGONISTS<br />

WITH POTENT ANTIHYPERGLYCEMIC<br />

AND ANTIHYPERLIPIDEMIC ACTIVITY<br />

• DERIVES D'ACIDES ARYLALCANOIQUES<br />

SUBSTITUES SERVANT D'AGONISTES DE<br />

PPAR PAN AYANT UNE FORTE ACTIVITE<br />

ANTIHYPERGLYCEMIQUE ET ANTIHYPER-<br />

LIPIDEMIQUE<br />

(73) Shenzhen Chipscreen Biosciences Ltd., Res.<br />

Inst. of Tsinghua Uni., Ste C301, P.O.Box 28,<br />

High-Tech Industrial Park, Nanshan District<br />

Shenzhen, Guangdong 518257, CN<br />

(72) LU, Xian-Ping Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

Li, Zhibin, Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong, CN<br />

LIAO, Chenzhong, Res. Inst. of Tsinghua<br />

Univ., Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

SHI, Leming, Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

LIU, Zhende, Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

MA, Baoshun, Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

NING, Zhiqiang, Res. Inst. of Tsinghua<br />

University, Nanshan District, Shenzhen,<br />

Guandong, CN<br />

SHAN, Song, Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

DENG, Tuo, Res. Inst. of Tsinghua University,<br />

Nanshan District, Shenzhen, Guangdong,<br />

CN<br />

(74) Howard, Paul Nicholas, et al, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

C07D 211/56 → (51) C07D 487/04<br />

C07D 213/<strong>02</strong> → (51) A61K 31/44<br />

C07D 213/76 → (51) C07C 311/29<br />

(51) C07D 215/18 (11) 1 631 550 B1<br />

(25) En (26) En<br />

(21) 03817134.4 (22) 06.06.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 08.03.2006<br />

(86) IN 2003/00<strong>02</strong>14 06.06.2003<br />

(87) WO 2004/108679 2004/51 16.12.2004<br />

(54) • VERBESSERTES VERFAHREN ZUR HER-<br />

STELLUNG VON MONTELUKASTSÄURE<br />

NATRIUMSALZ IN AMORPHER FORM<br />

• AN IMPROVED METHOD FOR THE PREP-<br />

ARATION OF MONTELUKAST ACID<br />

SODIUM SALT IN AMORPHOUS FORM<br />

• PROCEDE DE PREPARATION AMELIORE<br />

DE SEL DE SODIUM D'ACIDE MONTELU-<br />

KAST SOUS FORME AMORPHE<br />

(73) Morepen Laboratories Ltd., Medicus Division,<br />

505 Ansal Bhawan, 16 K.G. Marg, New<br />

Delhi 110 001, IN<br />

(72) SURI, Sanjay, Morepen Laboratories Limited,<br />

New Delhi 110 001, IN<br />

SINGH, Jujhhar, Morepen Laboratories Limited,<br />

New Delhi 110 001, IN<br />

565<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

SARIN, Gurdeep, Singh, Morepen Laboratories<br />

Ltd., New Delhi 110 001, IN<br />

TANWAR, Madan, Pal, Morepen Laboratories<br />

Limited, New Delhi 110 001, IN<br />

MAHENDRU, Manu, Morepen Laboratories<br />

Limited, New Delhi 110 001, IN<br />

(74) Goddar, Heinz J., et al, Forrester & Boehmert<br />

Pettenkoferstrasse 20-22, 80336 München,<br />

DE<br />

(51) C07D 217/22 (11) 1 794 128 B1<br />

A61K 31/47 A61P 9/12<br />

(25) De (26) De<br />

(21) 05784511.7 (22) 08.09.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 13.06.2007<br />

(86) EP 2005/009654 08.09.2005<br />

(87) WO 2006/032372 2006/13 30.03.2006<br />

(30) 23.09.2004 DE 1<strong>02</strong>004046492<br />

(54) • SUBSTITUIERTE 4-PHENYLTETRAHYD-<br />

ROISOCHINOLINE, VERFAHREN ZU IHRER<br />

HERSTELLUNG, IHRE VERWENDUNG ALS<br />

MEDIKAMENT, SOWIE SIE ENTHALTEN-<br />

DES MEDIKAMENT<br />

• SUBSTITUTED 4-PHENYLTETRAHYDROI-<br />

SOQUINOLINES, METHOD FOR THE PRO-<br />

DUCTION THEREOF, THEIR USE AS A<br />

MEDICAMENT, AND A MEDICAMENT<br />

CONTAINING THEM<br />

• 4-PHENYLTETRAHYDRO-ISOQUINOLINES<br />

SUBSTITUEES, PROCEDE PERMETTANT<br />

DE LES PRODUIRE, LEUR UTILISATION<br />

COMME MEDICAMENT ET MEDICAMENT<br />

LES CONTENANT<br />

(73) Sanofi-Aventis Deutschland GmbH,<br />

Brüningstraße 50, 65929 Frankfurt am Main,<br />

DE<br />

(72) LANG, Hans-Jochen, 65719 Hofheim, DE<br />

HEINELT, Uwe, 65926 Frankfurt am Main, DE<br />

WIRTH, Klaus, 65830 Kriftel, DE<br />

LICHER, Thomas, 65812 Bad Soden, DE<br />

HOFMEISTER, Armin, 55278 Dexheim, DE<br />

(74) Michalski Hüttermann & Partner <strong>Patent</strong>anwälte,<br />

Neuer Zollhof 2, 4<strong>02</strong>21 Düsseldorf, DE<br />

(51) C07D 217/24 (11) 1 566 380 B1<br />

C07D 401/04 C07D 401/06<br />

C07D 471/04 C07D 498/04<br />

C07D 513/04 A61K 31/472<br />

A61K 31/4725 A61K 31/4745<br />

A61K 31/496 A61K 31/5377<br />

A61P 9/10<br />

(25) Ja (26) En<br />

(21) 03774144.4 (22) 21.11.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 24.08.2005<br />

(86) JP 2003/014904 21.11.2003<br />

(87) WO 2004/048339 2004/24 10.06.2004<br />

(30) 22.11.20<strong>02</strong> JP 20<strong>02</strong>340174<br />

(54) • ISOCHINOLINVERBINDUNGEN UND IHRE<br />

MEDIZINISCHE VERWENDUNG<br />

• ISOQUINOLINE COMPOUNDS AND MED-<br />

ICINAL USE THEREOF<br />

• COMPOSES D'ISOQUINOLINONE ET LEUR<br />

UTILISATION A DES FINS MEDICINALES<br />

(73) Mitsubishi Tanabe Pharma Corporation, 2-<br />

10, Dosho-machi 3-chome Chuo-ku, Osakashi<br />

Osaka 541-8505, JP<br />

(72) FUJIO, M., MITSUBISHI PHARMA CORP.,<br />

Tokyo Off., Tokyo 103-8405, JP<br />

SATOH, H., MITSUBISHI PHARMA CORP.,<br />

Tokyo Off., Tokyo 103-8405, JP<br />

INOUE, S., MITSUBISHI PHARMA CORP.,<br />

Tokyo Off., Tokyo 103-8405, JP

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!